Presenting Science Vs.: Hunting A Killer Virus

Presenting Science Vs.: Hunting A Killer Viru...

Up next

Why No One Should Ever Use Air Dryers in Public Bathrooms

Should you use an air dryer or paper towels to dry your hands after washing them in a public bathroom? Dr. Sanjay Gupta shares his take. Plus, plasma donation is a growing trend across the country. Dr. Gupta digs into the reasons why and if there are any long-term health conseque ...  Show more

How to Help Your Parents Cut Down Their Screen Time

Screen time worries aren’t just for kids anymore. Families are seeing the same habits in parents and grandparents. Dr. Sanjay Gupta talks with psychiatrist Dr. Sue Varma about risks to the aging brain, warning signs and what families can do. Our show was produced by Kyra Dahring ...  Show more

Recommended Episodes

Combating COVID in the ER
Prognosis: Misconception

Doctors and nurses can feel as if they’re living in two worlds. One in which patients are getting sick and dying from the coronavirus, and another in which people deny the virus is real. Emergency room physician Mike Hunihan describes what it’s like to live and work with that dis ...  Show more

The Home Run Approach
Prognosis: Misconception

There's an innovative, but risky way we could speed up development of a COVID-19 vaccine. Some scientists argue we should intentionally infect volunteers with the coronavirus to get a vaccine sooner. How would it work? Today's special episode is a collaboration with Tradeoffs, a ...  Show more

Coronavirus: Are We Back Where We Started?
Science Vs

We’re six months into this coronavirus pandemic, which has shaken the world and stunned scientists. What have we learned? Where are we headed? To find out, we talk to virologist Professor John Dennehy, virologist and immunologist Professor Ann Sheehy, and hospital epidemiologist ...  Show more

Coronavirus: How Scary Are the Variants?
Science Vs

UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ...  Show more